Webinar: Targeting oxygen sensing in cancer
Posted: 8 January 2021 | Bio-Techne | No comments yet
This webinar from Bio-Techne discusses canonical and alternative oxygen sensing mechanisms implicated in cancer therapy resistance and recurrence.
![Bio-Techne feature image](https://www.drugtargetreview.com/wp-content/uploads/feature-image-8.jpg)
Hypoxia is an emerging hallmark of solid tumors. It is typically transduced to the nucleus of cancer cells by HIF-dependent transcription; however, recent evidence implies that other HIF-independent pathways are activated. This webinar from Bio-Techne discusses oxygen sensing mechanisms implicated in cancer therapy resistance and recurrence, and highlights evidence suggesting conventional chemotherapy might act as an oxygen-independent HIF inducer, thus promoting therapy failure and metastasis.
Related topics
Antibodies, Disease Research, Drug Targets, Metabolomics, Oncology
Related organisations
Bio-Techne